Arkolith/Insider Trading/RARE/Form 4

Huang Dennis Karl

See RemarksUltragenyx Pharmaceutical Inc. (RARE) · full profile →Form 4 · filed Mar 4, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 3, 2025Tax withholding(F)1K$42.92$58K115K
Mar 1, 2025Grant(A)18K—$0116K
Mar 1, 2025Grant(A)14K—$097K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 1, 2025Grant(A)26K—$026K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-032767) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML